Decision on Stock Split and Share Count Correction
-
Decision on 5:1 reverse stock split (par value from KRW 100 to KRW 500)
-
Total shares after split: 5,577,410 (corrected from 5,575,074)
-
2,336 fractional shares to be merged into treasury
-
Purpose: stabilize stock price and enhance corporate value through appropriate share count
-
Schedule: shareholder meeting 2026-03-31, effective 2026-04-16, trading suspension 2026-04-14~05-14, listing 2026-05-15
-
No capital reduction; subject to shareholder approval
KOSDAQ Filing Information
-
Filing: [Correction of Description] Decision on Stock Consolidation
-
Company: KMPHARMACEUTICAL (225430)
-
Submission: KMPHARMACEUTICAL Co.,Ltd.
-
Receipt: 05-07-2026
-
Under KRX KOSDAQ Market Division